ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
1 hedge funds and large institutions have $497K invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0.73% less ownership
Funds ownership: 2.09% → 1.36% (-0.73%)
20% less capital invested
Capital invested by funds: $620K → $497K (-$123K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$252K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
IMC Chicago
Chicago,
Illinois
| $497K | -$252K | -7,292 | -35% |
|
IWFL Hedge Fund Activity: Q4 2021 in Review
1 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q4 2021, worth a combined $497K — down 20% from $620K a quarter earlier.
Fund positioning in IWFL was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was IMC Chicago, cutting an estimated $252K.
- 1 institutional investor held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $497K of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q4 2021, down 20% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q4 2021 and 0 closed out.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN seller in Q4 2021 was IMC Chicago, an estimated $252K sold.
Based on aggregated 13F filings for Q4 2021.